img

Global IgA Nephropathy Drugs Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global IgA Nephropathy Drugs Market Research Report 2024

IgA nephropathy, also known as Berger's disease, is a kidney disease that occurs when IgA deposits build up in the kidneys, causing inflammation that damages kidney tissues. IgA is an antibody—a protein made by the immune system to protect the body from foreign substances such as bacteria or viruses.
According to Mr Accuracy reports’s new survey, global IgA Nephropathy Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole IgA Nephropathy Drugs market research.
Key companies engaged in the IgA Nephropathy Drugs industry include Calliditas Therapeutics, Travere Therapeutics, Omeros Corporation, Novartis International, Chinook Therapeutics, Vera Therapeutics and Otsuka Pharmaceutical, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of IgA Nephropathy Drugs were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole IgA Nephropathy Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global IgA Nephropathy Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Calliditas Therapeutics
Travere Therapeutics
Omeros Corporation
Novartis International
Chinook Therapeutics
Vera Therapeutics
Otsuka Pharmaceutical
Segment by Type
Phase I
Phase II
Phase III

Segment by Application


Clinical Treatment
Drug Experiment
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The IgA Nephropathy Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IgA Nephropathy Drugs Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.3 Market by Application
1.3.1 Global IgA Nephropathy Drugs Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Clinical Treatment
1.3.3 Drug Experiment
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global IgA Nephropathy Drugs Market Perspective (2018-2034)
2.2 IgA Nephropathy Drugs Growth Trends by Region
2.2.1 Global IgA Nephropathy Drugs Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 IgA Nephropathy Drugs Historic Market Size by Region (2018-2023)
2.2.3 IgA Nephropathy Drugs Forecasted Market Size by Region (2024-2034)
2.3 IgA Nephropathy Drugs Market Dynamics
2.3.1 IgA Nephropathy Drugs Industry Trends
2.3.2 IgA Nephropathy Drugs Market Drivers
2.3.3 IgA Nephropathy Drugs Market Challenges
2.3.4 IgA Nephropathy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IgA Nephropathy Drugs Players by Revenue
3.1.1 Global Top IgA Nephropathy Drugs Players by Revenue (2018-2023)
3.1.2 Global IgA Nephropathy Drugs Revenue Market Share by Players (2018-2023)
3.2 Global IgA Nephropathy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by IgA Nephropathy Drugs Revenue
3.4 Global IgA Nephropathy Drugs Market Concentration Ratio
3.4.1 Global IgA Nephropathy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IgA Nephropathy Drugs Revenue in 2024
3.5 IgA Nephropathy Drugs Key Players Head office and Area Served
3.6 Key Players IgA Nephropathy Drugs Product Solution and Service
3.7 Date of Enter into IgA Nephropathy Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IgA Nephropathy Drugs Breakdown Data by Type
4.1 Global IgA Nephropathy Drugs Historic Market Size by Type (2018-2023)
4.2 Global IgA Nephropathy Drugs Forecasted Market Size by Type (2024-2034)
5 IgA Nephropathy Drugs Breakdown Data by Application
5.1 Global IgA Nephropathy Drugs Historic Market Size by Application (2018-2023)
5.2 Global IgA Nephropathy Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America IgA Nephropathy Drugs Market Size (2018-2034)
6.2 North America IgA Nephropathy Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America IgA Nephropathy Drugs Market Size by Country (2018-2023)
6.4 North America IgA Nephropathy Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IgA Nephropathy Drugs Market Size (2018-2034)
7.2 Europe IgA Nephropathy Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe IgA Nephropathy Drugs Market Size by Country (2018-2023)
7.4 Europe IgA Nephropathy Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IgA Nephropathy Drugs Market Size (2018-2034)
8.2 Asia-Pacific IgA Nephropathy Drugs Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific IgA Nephropathy Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific IgA Nephropathy Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IgA Nephropathy Drugs Market Size (2018-2034)
9.2 Latin America IgA Nephropathy Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America IgA Nephropathy Drugs Market Size by Country (2018-2023)
9.4 Latin America IgA Nephropathy Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IgA Nephropathy Drugs Market Size (2018-2034)
10.2 Middle East & Africa IgA Nephropathy Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa IgA Nephropathy Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa IgA Nephropathy Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Calliditas Therapeutics
11.1.1 Calliditas Therapeutics Company Detail
11.1.2 Calliditas Therapeutics Business Overview
11.1.3 Calliditas Therapeutics IgA Nephropathy Drugs Introduction
11.1.4 Calliditas Therapeutics Revenue in IgA Nephropathy Drugs Business (2018-2023)
11.1.5 Calliditas Therapeutics Recent Development
11.2 Travere Therapeutics
11.2.1 Travere Therapeutics Company Detail
11.2.2 Travere Therapeutics Business Overview
11.2.3 Travere Therapeutics IgA Nephropathy Drugs Introduction
11.2.4 Travere Therapeutics Revenue in IgA Nephropathy Drugs Business (2018-2023)
11.2.5 Travere Therapeutics Recent Development
11.3 Omeros Corporation
11.3.1 Omeros Corporation Company Detail
11.3.2 Omeros Corporation Business Overview
11.3.3 Omeros Corporation IgA Nephropathy Drugs Introduction
11.3.4 Omeros Corporation Revenue in IgA Nephropathy Drugs Business (2018-2023)
11.3.5 Omeros Corporation Recent Development
11.4 Novartis International
11.4.1 Novartis International Company Detail
11.4.2 Novartis International Business Overview
11.4.3 Novartis International IgA Nephropathy Drugs Introduction
11.4.4 Novartis International Revenue in IgA Nephropathy Drugs Business (2018-2023)
11.4.5 Novartis International Recent Development
11.5 Chinook Therapeutics
11.5.1 Chinook Therapeutics Company Detail
11.5.2 Chinook Therapeutics Business Overview
11.5.3 Chinook Therapeutics IgA Nephropathy Drugs Introduction
11.5.4 Chinook Therapeutics Revenue in IgA Nephropathy Drugs Business (2018-2023)
11.5.5 Chinook Therapeutics Recent Development
11.6 Vera Therapeutics
11.6.1 Vera Therapeutics Company Detail
11.6.2 Vera Therapeutics Business Overview
11.6.3 Vera Therapeutics IgA Nephropathy Drugs Introduction
11.6.4 Vera Therapeutics Revenue in IgA Nephropathy Drugs Business (2018-2023)
11.6.5 Vera Therapeutics Recent Development
11.7 Otsuka Pharmaceutical
11.7.1 Otsuka Pharmaceutical Company Detail
11.7.2 Otsuka Pharmaceutical Business Overview
11.7.3 Otsuka Pharmaceutical IgA Nephropathy Drugs Introduction
11.7.4 Otsuka Pharmaceutical Revenue in IgA Nephropathy Drugs Business (2018-2023)
11.7.5 Otsuka Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global IgA Nephropathy Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Phase I
Table 3. Key Players of Phase II
Table 4. Key Players of Phase III
Table 5. Global IgA Nephropathy Drugs Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global IgA Nephropathy Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global IgA Nephropathy Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global IgA Nephropathy Drugs Market Share by Region (2018-2023)
Table 9. Global IgA Nephropathy Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global IgA Nephropathy Drugs Market Share by Region (2024-2034)
Table 11. IgA Nephropathy Drugs Market Trends
Table 12. IgA Nephropathy Drugs Market Drivers
Table 13. IgA Nephropathy Drugs Market Challenges
Table 14. IgA Nephropathy Drugs Market Restraints
Table 15. Global IgA Nephropathy Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global IgA Nephropathy Drugs Market Share by Players (2018-2023)
Table 17. Global Top IgA Nephropathy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgA Nephropathy Drugs as of 2024)
Table 18. Ranking of Global Top IgA Nephropathy Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by IgA Nephropathy Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players IgA Nephropathy Drugs Product Solution and Service
Table 22. Date of Enter into IgA Nephropathy Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global IgA Nephropathy Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global IgA Nephropathy Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global IgA Nephropathy Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global IgA Nephropathy Drugs Revenue Market Share by Type (2024-2034)
Table 28. Global IgA Nephropathy Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global IgA Nephropathy Drugs Revenue Market Share by Application (2018-2023)
Table 30. Global IgA Nephropathy Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global IgA Nephropathy Drugs Revenue Market Share by Application (2024-2034)
Table 32. North America IgA Nephropathy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America IgA Nephropathy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America IgA Nephropathy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe IgA Nephropathy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe IgA Nephropathy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe IgA Nephropathy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific IgA Nephropathy Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific IgA Nephropathy Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific IgA Nephropathy Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America IgA Nephropathy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America IgA Nephropathy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America IgA Nephropathy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa IgA Nephropathy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa IgA Nephropathy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa IgA Nephropathy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 47. Calliditas Therapeutics Company Detail
Table 48. Calliditas Therapeutics Business Overview
Table 49. Calliditas Therapeutics IgA Nephropathy Drugs Product
Table 50. Calliditas Therapeutics Revenue in IgA Nephropathy Drugs Business (2018-2023) & (US$ Million)
Table 51. Calliditas Therapeutics Recent Development
Table 52. Travere Therapeutics Company Detail
Table 53. Travere Therapeutics Business Overview
Table 54. Travere Therapeutics IgA Nephropathy Drugs Product
Table 55. Travere Therapeutics Revenue in IgA Nephropathy Drugs Business (2018-2023) & (US$ Million)
Table 56. Travere Therapeutics Recent Development
Table 57. Omeros Corporation Company Detail
Table 58. Omeros Corporation Business Overview
Table 59. Omeros Corporation IgA Nephropathy Drugs Product
Table 60. Omeros Corporation Revenue in IgA Nephropathy Drugs Business (2018-2023) & (US$ Million)
Table 61. Omeros Corporation Recent Development
Table 62. Novartis International Company Detail
Table 63. Novartis International Business Overview
Table 64. Novartis International IgA Nephropathy Drugs Product
Table 65. Novartis International Revenue in IgA Nephropathy Drugs Business (2018-2023) & (US$ Million)
Table 66. Novartis International Recent Development
Table 67. Chinook Therapeutics Company Detail
Table 68. Chinook Therapeutics Business Overview
Table 69. Chinook Therapeutics IgA Nephropathy Drugs Product
Table 70. Chinook Therapeutics Revenue in IgA Nephropathy Drugs Business (2018-2023) & (US$ Million)
Table 71. Chinook Therapeutics Recent Development
Table 72. Vera Therapeutics Company Detail
Table 73. Vera Therapeutics Business Overview
Table 74. Vera Therapeutics IgA Nephropathy Drugs Product
Table 75. Vera Therapeutics Revenue in IgA Nephropathy Drugs Business (2018-2023) & (US$ Million)
Table 76. Vera Therapeutics Recent Development
Table 77. Otsuka Pharmaceutical Company Detail
Table 78. Otsuka Pharmaceutical Business Overview
Table 79. Otsuka Pharmaceutical IgA Nephropathy Drugs Product
Table 80. Otsuka Pharmaceutical Revenue in IgA Nephropathy Drugs Business (2018-2023) & (US$ Million)
Table 81. Otsuka Pharmaceutical Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IgA Nephropathy Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global IgA Nephropathy Drugs Market Share by Type: 2024 VS 2034
Figure 3. Phase I Features
Figure 4. Phase II Features
Figure 5. Phase III Features
Figure 6. Global IgA Nephropathy Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global IgA Nephropathy Drugs Market Share by Application: 2024 VS 2034
Figure 8. Clinical Treatment Case Studies
Figure 9. Drug Experiment Case Studies
Figure 10. IgA Nephropathy Drugs Report Years Considered
Figure 11. Global IgA Nephropathy Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 12. Global IgA Nephropathy Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global IgA Nephropathy Drugs Market Share by Region: 2024 VS 2034
Figure 14. Global IgA Nephropathy Drugs Market Share by Players in 2024
Figure 15. Global Top IgA Nephropathy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgA Nephropathy Drugs as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by IgA Nephropathy Drugs Revenue in 2024
Figure 17. North America IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 18. North America IgA Nephropathy Drugs Market Share by Country (2018-2034)
Figure 19. United States IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Canada IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe IgA Nephropathy Drugs Market Share by Country (2018-2034)
Figure 23. Germany IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. France IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. U.K. IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Italy IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Russia IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Nordic Countries IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific IgA Nephropathy Drugs Market Share by Region (2018-2034)
Figure 31. China IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Japan IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. South Korea IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Southeast Asia IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. India IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Australia IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America IgA Nephropathy Drugs Market Share by Country (2018-2034)
Figure 39. Mexico IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Brazil IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa IgA Nephropathy Drugs Market Share by Country (2018-2034)
Figure 43. Turkey IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Saudi Arabia IgA Nephropathy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Calliditas Therapeutics Revenue Growth Rate in IgA Nephropathy Drugs Business (2018-2023)
Figure 46. Travere Therapeutics Revenue Growth Rate in IgA Nephropathy Drugs Business (2018-2023)
Figure 47. Omeros Corporation Revenue Growth Rate in IgA Nephropathy Drugs Business (2018-2023)
Figure 48. Novartis International Revenue Growth Rate in IgA Nephropathy Drugs Business (2018-2023)
Figure 49. Chinook Therapeutics Revenue Growth Rate in IgA Nephropathy Drugs Business (2018-2023)
Figure 50. Vera Therapeutics Revenue Growth Rate in IgA Nephropathy Drugs Business (2018-2023)
Figure 51. Otsuka Pharmaceutical Revenue Growth Rate in IgA Nephropathy Drugs Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries